The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Abstract
Synapse loss precedes cell death in Alzheimer's disease, but the timing of axon degeneration relative to these events, and the causal relationships remain unclear. Axons become so severely dystrophic near amyloid plaques that their interruption, causing permanent loss of function, extensive synapse loss, and potentially cell death appears imminent. However, it remains unclear whether axons are truly interrupted at plaques and whether cell bodies fail to support their axons and dendrites. We traced TgCRND8 mouse axons longitudinally through, distal to, and proximal from dystrophic regions. The corresponding neurons not only survived but remained morphologically unaltered, indicating absence of axonal damage signalling or a failure to respond to it. Axons, no matter how dystrophic, remained continuous and initially morphologically normal outside the plaque region, reflecting support by metabolically active cell bodies and continued axonal transport. Immunochemical and ultrastructural studies showed dystrophic axons were tightly associated with disruption of presynaptic transmission machinery, suggesting local functional impairment. Thus, we rule out long-range degeneration axons or dendrites as major contributors to early synapse loss in this model, raising the prospect of a therapeutic window for functional rescue of individual neurons lasting months or even years after their axons become highly dystrophic. We propose that multi-focal pathology has an important role in the human disease in bringing about the switch from local, and potentially recoverable, synapse loss into permanent loss of neuronal processes and eventually their cell bodies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another important factor might be the disruption of fast axonal transport, resulting in focal swellings filled with various organelles, as seen in the vicinity but also distant from plaques in several AD transgenic models [27,28,29,30], resembling Wallerian degeneration [31].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [27]
In the citing paper
“CRND8 APP mice reveal reduced synaptic markers and hippocampal neuronal loss at 6 months, when overlaps are first detected with cluster B modules (Adalbert et al., 2009; Brautigam et al., 2012).”
From Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models (2020) · cites this paper as Adalbert et al., 2009
In the citing paper
“Dysfunction of the endosomallysosomal system is also directly linked with Aβ deposition (Lee et al., 2022), oxidative stress (Wendt et al., 2022), and synaptic dysfunction (Adalbert et al., 2009).”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Adalbert et al., 2009
In the citing paper
“However, these dystrophic neurites are not entirely disrupted (Adalbert et al., 2009), suggesting that restoration of trafficking could still result in neuroprotective benefit.”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Adalbert et al., 2009
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00084-2 · Cited by 3,042
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955
Axon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819
Self-citationAxotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats
Berkelaar, M., Clarke, D., Wang, Y., Bray, G., & Aguayo, A. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04368.1994 · Cited by 814
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–176 of 176
Crowe, S. E., & Ellis‐Davies, G. C. R. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23306 · Cited by 15
Fonseca, E. A., Lafetá, L., Campos, J. L. E., Cunha, R. S., Barbosa, A. S., Romano‐Silva, M. A., Vieira, R. P., Malard, L. M., & Jório, A. (2021) · The Analyst · doi:10.1039/d1an01078f · Cited by 15
Wang, P., Shao, Y., Al‐Nusaif, M., Zhang, J., Yang, H., Yang, Y., Kim, K., Li, S., Liu, C., Cai, H., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00746-4 · Cited by 20
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14
Crowe, S. E., & Ellis‐Davies, G. C. R. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23336 · Cited by 14
Long live the axon. Parallels between ageing and pathology from a presynaptic point of view
Grillo, F. W. (2015) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2015.12.005 · Cited by 14
Klonarakis, M., Vos, M. D., Woo, E. K., Ralph, L. T., Thacker, J. S., & Gil‐Mohapel, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104541 · Cited by 14
Immunolocalization of Tom1 in relation to protein degradation systems in Alzheimer's disease
Makioka, K., Yamazaki, T., Takatama, M., Ikeda, M., Murayama, S., Okamoto, K., & Ikeda, Y. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.03.035 · Cited by 15
High-Resolution Digital Panorama of Multiple Structures in Whole Brain of Alzheimer's Disease Mice
Yin, X., Zhang, X., Zhang, J., Yang, W., Sun, X., Zhang, H., Gao, Z., & Jiang, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.870520 · Cited by 12
Tran, H. T., Tsai, E. H. R., Lewis, A. J., Moors, T. E., Bol, J. G. J. M., Rostami, I., Díaz, A., Jonker, A. J., Guizar‐Sicairos, M., Raabe, J., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.570019 · Cited by 11
The role of calsyntenin‐3 in dystrophic neurite formation in A lzheimer's disease brain
Uchida, Y., & Gomi, F. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12737 · Cited by 11
Lusch, B., Weholt, J., Maia, P. D., & Kutz, J. N. (2018) · Brain and Cognition · doi:10.1016/j.bandc.2018.02.012 · Cited by 11
Edgar, J. M., & Griffiths, I. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396460-1.00007-x · Cited by 13
Morrison, M., Maia, P. D., & Kutz, J. N. (2017) · Computational and Mathematical Methods in Medicine · doi:10.1155/2017/6102494 · Cited by 10
Zhou, J., Song, J., & Wu, S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14712 · Cited by 11
Merlo, S., Caruso, G. I., Bonfili, L., Spampinato, S. F., Costantino, G., Eleuteri, A. M., & Sortino, M. A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115151 · Cited by 10
A decade progress in the phenotyping of App knock-in mouse model of Alzheimer’s disease
Manabe, T., & Saito, T. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104959 · Cited by 13
Tau-mediated axonal degeneration is prevented by activation of the WldS pathway
Stubbs, K., Batchelor, B. G., Sivanantharajah, L., Sealey, M. A., Moreno, M. R., Ruiz, E., Richardson, B., Perry, V. H., Newman, T. A., & Mudher, A. K. (2023) · Brain Communications · doi:10.1093/braincomms/fcad052 · Cited by 9
dos Reis, R. R., Hennessy, E., Murray, C., Griffin, É. W., & Cunningham, C. M. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12232 · Cited by 10
Gunaseelan, S., Wang, Z., Kok, V. J. T., Ming, S. W. S., Razar, R. B. B. A., Srimasorn, S., Ong, W., Lim, K., & Chua, J. J. E. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa281 · Cited by 9
Kogure, C., & Tohda, C. (2017) · Traditional & Kampo Medicine · doi:10.1002/tkm2.1075 · Cited by 9
Fioriti, L., Wijesekara, N., Argyrousi, E. K., Matsuzaki, S., Takamura, H., Satoh, K., Han, K., Yamauchi, H., Staniszewski, A., Acquarone, E., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70030 · Cited by 8
Deolankar, S. C., Najar, M. A., Raghu, S. V., & Prasad, T. S. K. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0173 · Cited by 9
Ţolescu, R. Ş., Zorilă, M. V., Zăvoi, R. E., Popescu, C., Dumitru, I., Oprica, A. C., & Mogoantă, L. (2020) · PubMed Central · doi:10.12865/chsj.46.04.13 · Cited by 7
Maulik, M., Thinakaran, G., & Kar, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054605 · Cited by 7
The Unified Theory of Neurodegeneration Pathogenesis Based on Axon Deamidation
Joseph, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094143 · Cited by 6
Wan, Y., Al-Ouran, R., Mangleburg, C. G., Lee, T. V., Allison, K., Neuner, S., Kaczorowski, C. C., Phillip, V., Howell, G. R., Martini-Stoica, H., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/506873 · Cited by 5
Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?
Li, J., Huang, L., Liu, F., Tang, B., & Yan, X. (2017) · BMC Neurology · doi:10.1186/s12883-017-0942-y · Cited by 5
The neuropathology of Alzheimer’s disease
Masters, C. L. (2010) · CRC Press eBooks · doi:10.1201/b13196-64 · Cited by 5
Nishioka, C., Liang, H., Ong, S., & Sun, S. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.025 · Cited by 5
Yuan, Q., Zhang, H., Zhang, X., Huang, P., Liu, R., Song, Y., Wu, W., & Lin, Z. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.037 · Cited by 5
Maia, P. D., Raj, A., & Kutz, J. N. (2019) · Journal of Computational Neuroscience · doi:10.1007/s10827-019-00714-8 · Cited by 4
Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice
Sadleir, K. R., Popovoic, J., Zhu, W., Reidel, C. T., Do, H., Silverman, R. B., & Vassar, R. J. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210713125333 · Cited by 4
Poon, C., Pellow, C., & Hynynen, K. (2022) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20104 · Cited by 4
FGFR1 agonists alleviate pathology and cognitive impairment in an Alzheimer's disease mouse model
Hung, W.-C., Sun, W., Su, T., Lee, Y.-J., & Cheng, I. H.-J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115357 · Cited by 6
Maia, P. D., & Kutz, J. N. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1608.05778 · Cited by 3
Hou, W., Jia, Y., Li, Y., Wei, Z., Wen, X., Rao, C., Xu, X., Li, F., Wu, X., Sun, H., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.21.885988 · Cited by 3
Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease
Odfalk, K. F., Wickline, J. L., Smith, S., Dobrowolski, R., & Hopp, S. C. (2024) · Hippocampus · doi:10.1002/hipo.23586 · Cited by 2
Face processing in persons with and without Alzheimer's disease
Winchester, J. (2009) · Cited by 2
Gao, G., He, J., Luo, Y., Sun, Y., Zhou, Y., Zhang, J., Xing, Y., & Dai, J. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190405174908 · Cited by 2
Tekieh, T., Sasanpour, P., & Rafii‐Tabar, H. (2017) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/aaa378 · Cited by 1
Nichols, T. W. (2023) · Journal of Multiscale Neuroscience · doi:10.56280/1564010613 · Cited by 2
Imaging Microvascular Changes Associated with Neurological Diseases
Chugh, B. P. (2012) · TSpace (University of Toronto) · Cited by 1
Chen, Z., Peng, L., Zhao, M., Tao, L., Zou, P., & Zhang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-929763/v1 · Cited by 1
Snead, A. M., Patel, S., Krout, M., Hippman, R. S., Smith, G., Dileep, D., Chagoor, N., Shi, R., Linares-Saldana, R., Dobria, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.04.621986 · Cited by 2
Non‐amyloid Approaches To Alzheimer's Disease
Veng, L., Savage, M. J., Barrow, J. C., & Zerbinatti, C. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc253
Axon Death Prevented: Wlds and Other Neuroprotective Molecules: A Dissertation
Avery, M. A. (2010) · eScholarship@UMassChan · doi:10.13028/ejya-6w71
Knuesel, I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00004-2
In Vivo Visualization of Single Axons and Synaptic Remodeling in Normal and Pathological Conditions
Grillo, F. W., Canty, A. J., Bloomfield, P. S., & Paola, V. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801393-9.00011-6
Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
Dionísio, P. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
Farmácia, F. D. (2014)
Kurdakova, A. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5882
Axon swelling is electrophysiologically disruptive: A theoretically confirmed hypothesis
Tekieh, T., Rafii‐Tabar, H., & Sasanpour, P. (2016) · IEEE-EMBS Conference on Biomedical Engineering and Sciences · doi:10.1109/iecbes.2016.7843463
Assessing Cognition In A Mouse Model Of Alzheimer’s Disease
Mels, J. (2018) · Scholarship@Western (Western University)
Elucidating Mechanisms of Neurobehavioral Dysfunction in a Rodent Model of Traumatic Brain Injury
Logsdon, A. F. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6106
Kikuchi, T. (2021) · AIMS molecular science · doi:10.3934/molsci.2021024
Jain, K. K. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-272-8_18
In Vivo Imaging of Axonal Transport in Aging and Alzheimer’s Disease
Cross, D. J., & Minoshima, S. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_23
Fathy, Y. Y., Jonkman, L. E., Bol, J. G. J. M., Timmermans, E., Jonker, A. J., Rozemüller, A. J. M., & van de Berg, W. D. J. (2022) · Research Square · doi:10.21203/rs.3.rs-1767866/v1
Impact of Mediterranean and Ketogenic Diets on Alzheimer's Disease
Chen, L., Pan, J., & Wang, X. (2025) · Highlights in Science Engineering and Technology · doi:10.54097/ycwjkx45
Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E. R., Dugas, J. C., Pizzo, M. E., DeVos, S. L., Earr, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056383
Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E. R., Dugas, J. C., Pizzo, M. E., DeVos, S. L., Earr, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056359
Wang, P., Shao, Y., Al-Nusaif, M., Zhang, J., Yang, H., Yang, Y., Kim, K., Li, S., Liu, C., Cai, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26943114
Wang, P., Shao, Y., Al-Nusaif, M., Zhang, J., Yang, H., Yang, Y., Kim, K., Li, S., Liu, C., Cai, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26943117
Wang, P., Shao, Y., Al-Nusaif, M., Zhang, J., Yang, H., Yang, Y., Kim, K., Li, S., Liu, C., Cai, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26943120
Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E. R., Dugas, J. C., Pizzo, M. E., DeVos, S. L., Earr, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056422
Mitochondrial mechanics nucleates axonal jamming and swellingPreprint
Noerr, P. S., Abushawish, A. A., Pekkurnaz, G., & Rangamani, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.23.720276
Melecchi, A., Angeloni, E., Balzan, S., Calcagno, S., Canovai, A., Forini, F., Lademann, F., Lulli, M., Nicolini, G., Posarelli, C., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02913-0
Streamlined isolation of enriched axoplasm from primary dissociated neuronal cultures
Alarcón, S., Fuentes, A., Carrazana, E., Fabres, K., Bahamonde, P., Sanhueza, M., & Salvadores, N. (2026) · Methods · doi:10.1016/j.ymeth.2026.06.001
Story, B. D., Thomasy, S. M., Adelman, S. A., Taghian, T., LOPEZ, Y., Ardon, M., Shiraishi, H., Khan, S., Khan, M., Do, M., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.06.018
Wang, H., Wang, X., Gong, H., & Luo, H. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00498
Metadata
- Authors
- Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S. A., Kerschensteiner, M., Misgeld, T., & Coleman, M. P.
- Affiliations
- Babraham Institute (GB)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-05
- Volume
- 132
- Issue
- 2
- Pages
- 402-416
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2161240378
- Cited by
- 177
- References
- 60
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 15 · 2021: 9 · 2020: 11 · 2019: 10 · 2018: 5 · 2017: 9 · 2016: 16 · 2015: 10 · 2014: 6 · 2013: 12 · 2012: 21
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (069652/Z/02/Z)
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, axonal dystrophy, amyloid plaques, synaptic loss, axonal degeneration, axonal transport, neuronal survival, therapeutic window
- MeSH terms
- Alzheimer Disease, Animals, Axons, Breeding, Cell Survival, Immunohistochemistry, Male, Mice, Inbred C57BL, Microscopy, Electron, Nerve Degeneration, Synaptic Transmission, Neurons, Models, Animal, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
